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Post-transplant renal artery stenosis: The hemodynamic re- Renal artery stenosis is a well-known cause of post-
sponse to revascularization. transplant hypertension that can result in renal allograft
Background. Percutaneous transluminal angioplasty and dysfunction [1, 2]. The incidence ranges from 1 to 12%stenting are relatively noninvasive approaches to treat post-
depending on the definition of significant stenosis andtransplant renal artery stenosis. However, the real impact of
on the indications for arteriography [3]. Arteriographythis procedure on renal function recovery has never been quan-
titated precisely to date. is the definitive diagnostic method, but new noninvasive
Methods. In eight consecutive renal transplant patients with procedures such as Doppler ultrasonography may be
renal graft artery stenosis, blood pressure, body weight, and useful for screening of the disease [4].anatomical, functional, and Doppler ultrasound parameters
For many years, surgical correction has been the onlywere evaluated before and one month after renal artery translu-
treatment option for transplant renal artery stenosis, withminal angioplasty and stenting. On both occasions, glomerular
filtration rate and renal plasma flow were evaluated by inulin reported correction rates ranging from 63 to 92% [5].
and paraaminohippuric acid renal clearances, and glomerular The procedure, however, carries a significant risk of graft
size-selective function was evaluated by the fractional clear- loss, uretheral injury, reoperation, and mortality. On theances of neutral dextran macromolecules.
other hand, medical management may allow control ofResults. The correction of renal artery stenosis, by normaliz-
arterial hypertension but fails to restore kidney perfu-ing renal vascular resistances, fully restored kidney perfusion
and decreased arterial blood pressure, relieved water and sodium sion. In the last few years, percutaneous transluminal
retention, restored an almost laminar arterial blood flow, and revascularization has gained large popularity as a rela-
normalized vascular shear stress without appreciable effects on
tively noninvasive approach to improve both blood pres-glomerular barrier size-selective function and proteinuria. Pre-
sure control and kidney perfusion. The procedure mayangioplasty and postangioplasty renal resistive indices and peak
systolic blood velocity estimated by Doppler ultrasounds were be successful in up to 76% of cases, but its effectiveness
significantly correlated with the effective renal plasma flow and is strongly dependent on center experience and on the
the blood velocity calculated at the site of stenosis. All patients type of lesion [5]. Moreover, despite immediate success,
were discharged without sequelae one or two days after angio-
5 to 30% of treated renal artery stenoses show restenosisplasty.
six to eight months after the procedure, which may re-Conclusions. Percutaneous transluminal angioplasty and
stenting are safe and effective procedures to normalize the quire the use of endoprostheses, namely stents, as an
functional changes sustained by hemodynamically significant adjunctive therapy to angioplasty [6, 7]. Regardless of
artery stenosis after renal transplantation. Doppler ultrasound the adopted procedure, however, the real impact of re-scanning is a reliable and reproducible technique to monitor
perfusion on renal function recovery has not been quan-the renal functional response to vascular reperfusion.
titated precisely to date.
Actually, in addition to a decreased systemic blood
pressure, the relief of renal artery stenosis is assumed
to decrease prerenal resistance and to restore kidney
perfusion. It is conceivable that the consequent increaseKey words: stenosis, transplantation, vascular perfusion, Doppler ultra-
sound, hypertension, kidney perfusion, renal artery stenosis. in glomerular perfusion pressure and rate might alter
the intrinsic properties of the glomerular barrier, therebyReceived for publication August 31, 2000
facilitating the passage of circulating proteins into theand in revised form November 20, 2000
Accepted for publication January 26, 2001 Bowman’s space [8, 9]. On the other hand, the attendant
improvement in perfusion might elevate the glomerular 2001 by the International Society of Nephrology
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filtration rate (GFR), thereby making it possible for the and the glomerular barrier size selectivity was assessed
by the fractional clearances of neutral dextran test mole-filtered protein load to increase without an accompa-
nying change in filtration barrier charge or size selectiv- cules (Methods section). Then a selective renal artery
angiography was performed. One additional patient withity. To distinguish these possibilities, we studied patients
with renal artery stenosis before and after angioplasty severe (Leriche class III-IV) peripheral artery disease
was studied during an angiographic evaluation of bothand stenting, and compared the urinary protein excretion
to the clearance of a broad-size distribution of neutral iliac and femoral arteries, despite no echo-Doppler evi-
dence of renal artery stenosis.dextrans. Because the test dextran preparation was un-
charged and because dextran was excreted solely by glo-
Angioplasty and stent deploymentmerular filtration and neither secreted into nor reab-
sorbed from the tubule lumen [10, 11], any changes in A transluminal angioplasty combined to a stent de-
ployment was performed whenever a50% renal arteryits urinary clearance relative to that of freely permeable
inulin should reflect the alterations in the size-selective stenosis—that is, a stenosis considered hemodynamically
relevant [7, 12]—was detected. The degree of stenosisproperties of the glomerular filter uniquely. Thus, the
present study was primarily aimed at comparing renal was measured before and immediately after the proce-
dure by use of a millimetric ruler. The percentage ofhemodynamics and glomerular size-selective function
before and after angioplasty by ad hoc renal clearance stenosis (S%) was determined using this formula:
protocols. Moreover, the measured changes in renal
S%  (Do  Ds)/Do (Eq. 2)plasma flow (RPF) and vascular resistances were com-
pared with the changes in blood flow velocity profiles where Do is the reference diameter, and Ds is the diame-
ter at the site of stenosis. Do was measured at a segmentrecorded from the renal artery and parenchyma by
Doppler ultrasound scanning. This served to evaluate of an uninvolved renal artery.
Ipsilateral femoral artery puncture was performed,whether Doppler ultrasonography was a reliable and
reproducible technique to monitor the renal functional and a 7F introducer sheath was inserted. Standard bal-
loon angioplasty was performed before stent deploy-response to vascular reperfusion.
ment. The selected balloon diameter was equal to the
diameter of the transplant renal artery. Then a balloon-
METHODS
expandable stent (Palmaz Cardis Stent; Johnson & John-
Patient selection and baseline evaluation son, Princeton, NJ, USA) was implanted. The stent diame-
ter was the same as the largest percutaneous transluminalAll renal transplant patients referred to the Outpatient
Clinic of the Unit of Nephrology of the Ospedali Riuniti, angioplasty balloon used. After stent deployment, an
intrastent angioplasty was performed when the diameterAzienda Ospedaliera of Bergamo, because of suspected
renal artery stenosis were asked to enter the study. Only within the stent was less than the reference diameter of
the artery. The selective renal artery angiography wasthose providing written informed consent according to
the declaration of Helsinki were selected for study partic- repeated immediately after the completion of the proce-
dure to verify and quantitate the achieved dilation of theipation. All selected cases were referred to the Clinical
Research Center for Rare Diseases “Aldo & Cele Dacco`” stenotic tract. The procedure was considered successful
when residual stenosis was 0%. A 24-hour heparinizationVilla Camozzi, Ranica, where an ultrasound evaluation
was carried out with an Ultramark 9 HDI device (Ad- and antiplatelet treatment (aspirin 100 mg/day) was
given to all patients. The patients were discharged onevanced Technology Laboratories, Bothell, WA, USA),
employing a 7-4 MHz convex probe. Color flow Doppler to two days after the procedure.
was performed according to a predefined diagnostic pro-
Follow-uptocol aimed to detect blood flow turbulences and in-
creased peak systolic velocity in the renal graft artery, A second ultrasound evaluation was repeated one
month later to verify and quantitate the changes in peakand to quantitate intrarenal vascular resistance by calcu-
lating the resistive index (RI) using this formula: systolic velocities and intrarenal resistive indices as com-
pared with baseline. On the same occasion, the renal
RI  (PSF  LDF)/PSF (Eq. 1)
clearances were repeated according to the same protocol
described for baseline evaluations (see next section).where PSF is the peak systolic frequency shift and LDF
is the lowest diastolic frequency shift. At least three The primary clinical and laboratory parameters—includ-
ing systolic, diastolic, and mean arterial blood pressure,different measures were performed on each graft. In all
patients with clinical and instrumental (Doppler) suspi- body weight, serum creatinine and creatinine clearance,
24-hour urine protein excretion rate, routine hemato-cion of a hemodynamically significant renal graft artery
stenosis, GFR and RPF were measured by inulin and chemistry, and immunosuppressive and antihypertensive
therapy—were recorded at each of the two clearancepara-aminohippuric acid (PAH) clearances, respectively,
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study time points. Any serious or nonserious adverse rameters are given in the Appendix. Separation of
graded-size dextran molecules and inulin in plasma andevent was carefully monitored up to resolution and was
recorded in the patient case record form. urine samples was performed by gel permeation chroma-
tography on a Sephacryl S-300 column (1.6  95 cm),
Functional studies as previously described [14, 15]. Column calibration was
performed using dextran standards of known molecularAll patients underwent solute clearance studies shortly
after Doppler ultrasound evaluation and one month after weight (Pharmacosmos, Viby Sj., Denmark).
The molecular radius of individual dextran fractionsthe renal artery angiography and transluminal angio-
plasty. The time lag between angioplasty and the clear- was calculated according to direct measurements of dex-
tran standards as reported by Oliver et al, which relateance studies was aimed at eliminating any potential and
transient confounding effect of radiocontrast toxicity on to effective molecular radii and mean molecular weight
of these macromolecules [17]. Dextran and inulin con-the renal function parameters. Exactly the same proce-
dure was used for each patient in all functional evalua- centrations were assayed in eluted fractions using colori-
metric methods as previously described [14, 15, 18]. Thetions. After overnight fasting, on the morning of the
clearance studies, patients were admitted to a Metabolic urine-to-plasma concentration ratio for inulin was calcu-
lated from inulin concentrations in eluted fractions. TheWard and submitted a 24-hour urine collection for the
evaluation of creatinine clearance and urinary urea, so- fractional clearance of dextran macromolecules was then
computed as follows:dium, and total protein excretion. They were given their
usual immunosuppressive therapy except for cyclospo-
D  (U/P)D /(U/P)IN (Eq. 3)rine, which was administered only after completion of
the clearance studies in order to avoid the confounding where (U/P)D and (U/P)IN are the urine-to-plasma con-
centration ratios of dextran and inulin, respectively.effect of acute cyclosporine-induced changes in renal
hemodynamics [13]. Antihypertensive therapy and di- Other laboratory measurements were performed using
uretics were withdrawn until the end of the study, and routine laboratory techniques.
only sublingual nifedipine was allowed in selected cases
Statistical analysisto control severe or symptomatic hypertension through-
out the clearance studies. A constant diuresis was in- Data were expressed as mean  SD or median and
duced by oral water loading. As soon as a steady-state range as specified. Statistical analysis was performed us-
diuresis was achieved, inulin, PAH, and neutral dextran ing the analysis of variance (ANOVA), and specific com-
clearances were performed, as described in detail pre- parisons between different group means were performed
viously (in one patient with previous history of allergy, using the two-tailed Student t test for paired data. Corre-
neutral dextrans were not injected) [14, 15]. Briefly, lation analyses were done using Pearson r coefficients.
primed infusion of inulin and PAH was immediately Statistical analysis was performed using the software
followed by a slow intravenous administration (about 15 package Statwiew (Abacus Concepts Inc., Berkeley, CA,
min) of Dextran-40 (130 mg/kg, Rheomacrodex; Phar- USA). The statistical significance level was defined as
macia, Uppsala, Sweden). A sustained infusion of inulin P  0.05.
and PAH was continued throughout the study to main-
tain constant plasma concentrations. After an equilibra-
RESULTStion period of approximately 60 minutes, three exactly
Eight consecutive renal transplant patients (6 men andtimed urine collections of 30 minutes each were made
2 women) referred to the Clinical Research Center fromby spontaneous voiding. Blood samples were collected
October 1994 to October 1999 completed the study. Theyat the beginning and the end of each clearance period.
were 37 (range of 20 to 61) years old and had received aUrine and plasma samples obtained during the first clear-
cadaveric kidney graft a mean of 26 (range of 3 to 94)ance period were used to determine fractional clearance
months before. They were on chronic, oral immunosup-of dextran molecules of graded size (effective molecular
pressive therapy with a mean dose of cyclosporine Aradius ranging from 26 to 66 A˚).
microemulsion (Sandimmun Neoral) of 3.9 (range of 1.9
Analytical methods to 6.7) mg/kg/day and prednisone (5 to 12 mg/day). Four
patients also were receiving mofetil micophenolate (1 orInulin and PAH concentrations in plasma and urine
2 g/day) and four azathioprine (50 to 200 mg/day). Allsamples were determined using previously described
patients were on chronic antihypertensive therapy withmethods [14, 15]. GFR was calculated as the average
one drug (N  2), two drugs (N  2), two drugs plus ainulin clearance. Effective RPF (ERPF) was calculated
diuretic (N  3), or three drugs (N  1). Seven patientsfrom the average PAH clearance, assuming, as reported
were on atenolol (50 to 100 mg/day) and five on nifedi-previously [16], a renal extraction coefficient for PAH
of 0.9. Methods for calculating the other functional pa- pine (30 to 60 mg/day). No patient was receiving angio-
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Table 2. Main functional and anatomical parameters before andTable 1. Main clinical parameters before and after angioplasty (AP)
after angioplasty (AP)
Before AP After AP P value
Before AP After AP P value
Body weight kg 71.715.4 69.114.8 0.01
SBP mm Hg 1505 1437 0.05 GFR mL/min/1.73 m2 44.913.0 50.99.7 NS
ERPF mL/min/1.73 m2 319122 456179 0.05DBP mm Hg 949 9211 NS
MBP mm Hg 1137 1099 NS FF % 155 124 0.01
RVR mm Hg/mL/min/1.73 m2 23.19.7 15.96.0 0.05HR beats/min 61.55 574 NS
RI 0.520.12 0.630.06 0.01Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pres-
SPV cm/s 384195 15538 0.01sure; MBP, mean blood pressure; HR, heart rate; NS, not significant.
Area mm2 3.62.4 27.45.9 0.01
Reynolds’ number 1892396 888227 0.01
Wall shear stress dynes/cm2 551342 217 0.01
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective renal
tensin-converting enzyme inhibitors or angiotensin II re- plasma flow; FF, filtration fraction; RVR, renal vascular resistances; RI, resistive
index; SPV, systolic peak velocity; NS, not significant.ceptor antagonists. The main clinical and laboratory
parameters at study entry are summarized in Tables 1
and 2.
Renal artery stenosis presented with newly onset or one patient (of note, the one with the highest prestenting
worsening hypertension in all patients combined to in- values), and the peak systolic velocity did not change
creasing serum creatinine concentration in six cases. At in another one. Thus, after the procedure, all patients
study entry, color-flow Doppler ultrasonography showed showed a change in at least one of the Doppler ultra-
decreased resistive indices and increased peak systolic sound parameters considered.
artery velocities (Table 2). All patients had depressed These echographic changes most likely reflected the
GFR and ERPF and increased renal vascular resistances significant increase in ERPF and the parallel decrease
and filtration fraction (Table 2). The selective renal ar- in RVR that were uniformly observed in all functional
tery angiography detected a stenosis at the anastomotic studies after the procedure (Table 2 and Figs. 3 and 4).
site in seven patients, whereas a postanastomotic stenosis This interpretation is consistent with findings of a sig-
was seen in one patient. The degree of stenosis ranged nificant negative correlation between resistive indices
from 55 to 90%, and the residual cross-sectional area, and ERPF (r 0.54, P 0.03) and between peak systolic
calculated at the stenotic site, ranged from 1.2 to 7.0 mm2 blood velocity and effective blood velocity calculated at
(Table 2). the site of stenosis or stenting (r  0.77, P  0.0005).
Standard balloon angioplasty was performed before Improved kidney perfusion was sustained by a remark-
stent deployment in all patients. The procedure was a able and highly significant increase in the artery cross-
technical success with no residual stenosis in all patients. sectional surface area (Table 3). Mean wall shear stress
Representative angiograms taken from two patients be- and mean Reynolds’ number, calculated at the site of
fore (left panel) and after (right panel) stenting are renal artery stenosis, were remarkably elevated above
shown in Figure 1. In the study group as a whole, correc- normal values in all patients. After stent deployment,
tion of the stenosis was associated with a significant re- both indices decreased within the normal ranges in the
duction in systolic (but not in mean or diastolic) blood study group as a whole and in each individual patient
pressure (Table 1), despite the concomitant reduction in (Table 2 and Fig. 5). However, despite a full correction
the number and dose of antihypertensive drugs in five of the stenosis, GFR did not change significantly after the
patients. After the procedure, the number of patients on procedure (Fig. 3). This, in parallel with the remarkable
one antihypertensive drug (including a diuretic in one increase in ERPF, accounted for a significant decrease
case) increased from two to five. Two patients were still in filtration faction (Fig. 4). Of note, prestenting and
on two drugs and one patient on three drugs. The number poststenting filtration fraction and ERPF were nega-
of patients on atenolol decreased from seven to four tively correlated (r 0.79, P 0.0003). Serum creatinine
(unchanged doses), and of those on nifedipine from five concentration and creatinine clearance did not change
to four (halved doses in 2 cases). Only one patient (the significantly (Table 3). Sodium and free-water clearances
one on 3 drugs) remained on the same prestenting anti- increased, albeit nonsignificantly, after stent deployment
hypertensive therapy. Also, the body weight significantly (Table 3).
decreased by approximately 2.5 kg (Table 1) in parallel On the other hand, the prestenting and poststenting
with a trend to higher sodium and free water clearances 24-hour urinary protein excretion rates (Table 3) and neu-
(Table 3). tral dextran sieving profiles (Fig. 6) were almost identical.
As expected, after the procedure, the mean intraparen- Finally, the procedure was well tolerated, and no pa-
chymal-resistive indices increased in parallel with a sig- tient experienced serious complications (including trau-
nificant reduction in mean peak renal artery systolic ve- matic lesions, bleeding, or thrombosis) or recurrence of
the stenosis over a mean follow-up of 25 (5 to 62) months.locities (Table 2 and Fig. 2). The RI did not increase in
Ruggenenti et al: Post-transplant renal artery stenosis 313
Fig. 1. Representative angiograms taken from
two patients before (left panel) and after
(right panel) stenting.
Table 3. Main laboratory parameters before and stenosis was effectively corrected by transluminal angio-
after angioplasty (AP)
plasty with a prompt decrease in arterial blood pressure
Before AP After AP and progressive improvement of renal function.
Serum creatinine mg/dL 1.750.5 1.530.43
Total plasma proteins g/dL 6.30.4 6.20.6
Hematocrit % 40.44.2 38.94.2 DISCUSSION
Creatinine clearance mL/min/1.73 m2 63.127.8 63.221.8
To our knowledge, this is the first study of kidneyNa clearance mL/min/1.73 m2 2.81.5 4.02.4
Free water clearance mL/min/1.73 m2 3.42.9 4.52.6 transplant patients designed to investigate renal hemo-
Urinary protein excretion g/24 h 0.300.25 0.370.49 dynamics before and after intraluminal correction of a
functionally significant artery stenosis. Results show that
angioplasty and stent deployment effectively and safely
corrected hemodynamically significant stenoses and
All patients were discharged without sequelae within ameliorated kidney perfusion, besides improving blood
two days after the interventional procedure. pressure control. Moreover, the renal hemodynamic re-
At one year, systolic blood pressure was 132  15 sponse to reperfusion could be reliably monitored by
mm Hg (P 0.05 vs. preangioplasty and stenting values). Doppler ultrasound scanning.
Diastolic blood pressure was 89 12 mm Hg, and serum Diagnosis of hemodynamically significant renal artery
creatinine concentration was 1.7  0.7 mg/dL (P  NS, stenosis rests on a radiological demonstration of 	50%
vs. one-month parameters). Over a median (range) fol- reduction in renal artery diameter [7, 12]. The rationale
low-up of 32 (12 to 70) months, blood pressure and serum for this assumption is derived from experimental evi-
creatinine were stable, and no change in antihypertensive dence that the stenosis needs to occlude at least 50% of
therapy was introduced in any of the patients except the lumen before renal blood flow and perfusion pressure
one. This patient was admitted on November 2000 (ex- start to decrease and systemic blood pressure to increase
actly one year after angioplasty and stenting) because [12]. Thus, the finding that a radiologically documented
of increasing arterial blood pressure and worsening renal 	50% renal artery stenosis in all of our patients was
function. A selective renal artery angiography detected associated with remarkably increased renal vascular re-
a restenosis at the site of stent deployment, inducing a sistances and decreased ERPF provides direct evidence,
to our knowledge for the first time, that this assumption50% reduction in the vascular cross-sectional area. The
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Fig. 3. Prestenting and poststenting glomerular filtration rate (GFR)
(A) and effective renal plasma flow (ERPF) (B) measured in eachFig. 2. Prestenting and poststenting peak blood velocity (A) and re-
individual patient.sistive indices (B) measured by echo-color Doppler in each patient.
substantial reduction of ERPF. A high filtration fractionalso can be properly extended to humans. Of note, all
might in turn depend on a relative increase in postglo-patients were cured by the angioplasty combined with
merular resistance that would maintain glomerular fil-stent deployment with no residual stenosis after the pro-
tration, as suggested by studies in experimental modelscedure. The findings that the intervention decreased re-
[10, 19, 20]. Actually, while in humans, direct measure-nal vascular resistances and restored kidney perfusion
ments of intracapillary pressure are not feasible, rat datadespite a slight concomitant decrease in arterial blood
are available showing that renal artery stenosis is fol-pressure provides additional indirect evidence of the he-
lowed by a postglomerular vasoconstriction, which main-modynamic relevance of the stenosis.
tains the intracapillary pressure despite the decreasedBefore angioplasty, depressed ERPF was associated
renal perfusion pressure [10, 19, 20]. Of interest, restor-with less-depressed GFR and increased filtration frac-
ing kidney perfusion relieves postglomerular vasocon-tion. Conceivably, GFR was relatively maintained by
the remarkable increase in filtration fraction facing a striction, which leads to a decrease of filtration fraction
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Fig. 5. Prestenting and poststenting Reynolds’ number (A) and mean
Fig. 4. Prestenting and poststenting filtration fraction (FF) (A) and wall shear stress (B) measured in each individual patient.
renal vascular resistance (RVR) (B) measured in each individual pa-
tient.
apply to our patient population is suggested by our pa-
tients’ remarkable weight loss and by the trend to in-to normal ranges [10, 19, 20]. Thus, the finding that re-
creased sodium and free water clearances observed onestoring kidney perfusion was associated with a decreased
month after transluminal angioplasty and stenting. Col-filtration fraction in our patients indicated, albeit indi-
lectively, these data indicate that the trend to a bloodrectly, that after angioplasty and stenting the GFR was
pressure reduction in our patients was at least in partless dependent on postglomerular vasoconstriction. This
dependent on the relief of sodium and water retentioninterpretation is consistent with the finding that the pre-
sustained by kidney hypoperfusion.stenting and poststenting filtration fraction and ERPF
To evaluate the effect of kidney reperfusion on glo-were negatively correlated.
merular size-selective function, we compared the clear-In animals, resolution of one-kidney, one-clip reno-
ances of neutral dextrans of a broad-size distributionvascular hypertension has been associated with prompt
diuresis and natriuresis [21, 22]. That this might possibly relative to those of free-permeable inulin measured be-
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mean wall-shear stress dramatically exceeded (by more
than one order of magnitude) physiological values that
range between 10 and 30 dynes/cm2 [33]. Blood flow
turbulence and elevated shear stress are recognized as
determinants of endothelial dysfunction and progressive
vascular injury, and have been implicated in thrombotic
vascular occlusion in atherosclerotic disease [33, 34]. Thus,
because of the remarkable increase in secondary flows
and turbulence, and the elevation of wall shear stress
found at the renal artery stenosis site, it could be inferred
that, if untreated, these patients would be at risk for renal
artery thrombosis that would eventually lead to graft loss.
Of note, angioplasty and stent deployment allowed the
achievement of an important reduction of Reynolds’
number (570 to 1240) and lowered mean wall shear stress
values to within the normal range in all individual pa-
tients (values ranging from 13 to 34 dynes/cm2).
Finally, we observed that renal artery stenosis was
accompanied by a remarkable increase in peak blood
flow velocities and decreased resistive indices recorded
Fig. 6. Prestenting () and poststenting () fractional clearances of by Doppler ultrasound scanning from the renal artery
neutral dextrans of different radii.
and parenchyma, respectively. Both parameters fully
normalized in parallel with the relief of the stenosis. Of
note, the findings that changes in peak systolic velocities
were negatively correlated with ERPF, but were posi-fore and after angioplasty and stenting. Indeed, both
tively correlated to a highly significant extent with thein experimental [23–25] and human [26–29] proteinuric
actual flow velocity at the stenosis site, strongly suggestednephropathies, maneuvers—such as colloid volume ex-
that this echographic parameter is a reliable indicator ofpansion or fluid immersion—that increase glomerular
stenosis severity. Even more interesting, parenchymal-perfusion induce an increase in proteinuria accompanied
resistive indices, which currently are taken to reflectby an emergence of larger pores (“the shunt pathway”)
overall intrarenal resistances, were uniformly decreasedand decreased glomerular barrier size selectivity [29, 30].
in all of our cases of post-transplant renal artery stenosis.In normal individuals, however, the opening of larger
Most likely this would depend on an intrarenal vasodila-pores is not accompanied by an increase in neutral dex-
tion finalized to maintain kidney perfusion despite atran ultrafiltration and proteinuria, since the effects of
poststenotic drop in arterial pressure. This assumptiona reduced glomerular barrier size selectivity sustained
is in harmony with findings of a negative correlationby the augmented shunt pathway are nullified by the
between the changes in intrarenal-resistive indices andtendency for high plasma flows to decrease fractional
the extent of artery stenosis or peak systolic velocities.clearances [31]. Of interest, the comparable neutral dex-
Taken together, these data suggest that Doppler ultra-tran sieving profiles observed in our patients before and
sound scanning is a useful, reliable, and noninvasive toolafter angioplasty and stenting most likely reflected the
to monitor the renal functional response to artery revas-opposite effects of decreased intrinsic glomerular barrier
cularization.selectivity and increased glomerular perfusion rate pre-
In conclusion, renal graft artery stenosis is effectivelyviously observed in healthy individuals [31]. The finding
and safely corrected by transluminal renal artery angio-that net macromolecules ultrafiltration and urinary pro-
plasty and stent deployment. Correcting the renal arterytein excretion were not substantially affected by angio-
stenosis improved blood pressure control, fully restoredplasty suggest that the maneuver does not increase pro-
tein traffic and tubular protein overload and, therefore, kidney perfusion, relieved the reflex postglomerular va-
soconstriction, and normalized blood flow and vascularshould not have a long-term detrimental effect on kidney
graft function [32]. shear stress without inducing appreciable and potentially
detrimental acute increases in intracapillary pressureAn additional interesting finding of the present study
was that at the site of the stenosis, the blood flow was and/or glomerular barrier permeability. Doppler ultra-
sound scanning is a reliable and reproducible techniqueimportantly disturbed and almost turbulent, as suggested
by the high Reynolds’ number calculated for each patient to monitor the renal functional response to revasculari-
zation.(1260 to 2405; Fig. 5). At the same time, the calculated
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